We reason that the reduction of nucleobindin-1 protein in EVs, which additionally appear to be present in an altered phosphorylation status, may indicate that nucleobindin-1 function (possibly in both the cell and the released EVs) is impaired (reduced) in the pancreas of T1D patients. Here, NUCB1 is linked to type 1 diabetes mellitus.